Biomedical papers, 2016 (vol. 160), issue 1

Biomed Pap Med Fac Univ Palacky Olomouc Czech Repub. 2016, 160(1):76-83 | 10.5507/bp.2015.016

TLR2 and TLR4 expression on CD14++ and CD14+ monocyte subtypes in adult-onset autoimmune diabetes

Pavlina Cejkovaa,b, Iva Nemeckovaa, Jan Brozc, Marie Cernab
a Department of Anthropology and Human Genetics, Faculty of Science, Charles University in Prague, Czech Republic
b Department of General Biology and Genetics, Third Faculty of Medicine, Charles University in Prague, Czech Republic
c 2nd Department of Internal Medicine, Diabetes Center, Third Faculty of Medicine, Charles University in Prague, Czech Republic

Background: Peripheral blood monocytes are key effectors of innate immunity. Dysfunction, changes in their counts or altered expression of cytokines and pattern-recognition receptors on monocytes may contribute to the development of the autoimmune type of diabetes mellitus (AD).

Aims: We aimed to analyze the counts and proportions of the two main subtypes of monocyte cells, CD14++ and CD14+, and to look for potential changes in the expression of toll-like receptors 2 (TLR2) and 4 (TLR4) as well as cytokine prolactin (PRL) in adult-onset AD, including diabetes mellitus type 1 (T1DM) and latent autoimmune diabetes in adults (LADA).

Methods: We examined 21 T1DM patients, 9 patients with LADA, 16 control patients with type 2 diabetes mellitus (T2DM) and 24 healthy individuals. All diabetic patients were diagnosed after the age of 18 years. Expression at the mRNA level was determined by quantitative PCR. Flow cytometry was used to ascertain membrane expression and cell counts.

Results: T1DM patients had fewer CD14++ (P < 0.01) and CD14+ (P < 0.0001) monocytes whereas T2DM subjects showed decreased counts of CD14+ monocytes compared to healthy controls (P < 0.001). TLR2 protein expression was significantly increased in T1DM CD14+ monocytes compared to healthy controls (P < 0.05), while TLR4 expression in T1DM CD14++ cells was significantly lower (P < 0.0001). There was no significant difference between the groups in terms of PRL mRNA expression in monocytes.

Conclusions: The observed changes in the proportions of both immune cell types and in the expression of functional pattern-recognition receptors on monocytes in the subjects examined may arise as a consequence of chronic inflammation that accompanies long-term diabetes.

Keywords: adult-onset autoimmune diabetes, CD14 monocyte, inflammation, prolactin, toll-like receptor

Received: December 22, 2014; Accepted: April 1, 2015; Prepublished online: May 4, 2015; Published: March 30, 2016


References

  1. Wells CA, Chalk AM, Forrest A, Taylor D, Waddell N, Schroder K, Himes SR, Faulkner G, Lo S, Kasukawa T, Kawaji H, Kai C, Kawai J, Katayama S, Carninci P, Hayashizaki Y, Hume DA, Grimmond SM. Alternate transcription of the Toll-like receptor signaling cascade. Genome Biology 2006;7(2). Go to PubMed...
  2. Ziegler-Heitbrock L. The CD14+CD16+blood monocytes: their role in infection and inflammation. Journal of Leukocyte Biology 2007;81:584-92. Go to original source... Go to PubMed...
  3. Ziegler-Heitbrock L, Ancuta P, Crowe S, Dalod M, Grau V, Hart DN, Leenen PJM, Liu YJ, MacPherson G, Randolph GJ, Scherberich J, Schmitz J, Shortman K, Sozzani S, Strobl H, Zembala M, Austyn JM, Lutz MB. Nomenclature of monocytes and dendritic cells in blood. Blood 2010;116:E74-E80. Go to original source... Go to PubMed...
  4. Rossol M, Kraus S, Pierer M, Baerwald C, Wagner U. The CD14brightCD16+monocyte subset is expanded in rheumatoid arthritis and promotes expansion of the Th17 cell population. Arthritis and Rheumatism 2012;64:671-7. Go to original source... Go to PubMed...
  5. Mysliwska J, Smardzewski M, Marek-Trzonkowska N, Mysliwiec M, Raczynska K. Expansion of CD14(+)CD16(+) monocytes producing TNF-alpha in complication-free diabetes type 1 juvenile onset patients. Cytokine 2012;60:309-17. Go to original source... Go to PubMed...
  6. Krankel N, Armstrong SP, McArdle CA, Dayan C, Madeddu P. Distinct Kinin-Induced Functions Are Altered in Circulating Cells of Young Type 1 Diabetic Patients. Plos One 2010;5(6). Go to original source... Go to PubMed...
  7. Macaubas C, Nguyen KD, Peck A, Buckingham J, Deshpande C, Wong E, Alexander HC, Chang SY, Begovich A, Sun Y, Park JL, Pan KH, Lin R, Lih CJ, Augustine EM, Phillips C, Hadjinicolaou AV, Lee T, Mellins ED. Alternative activation in systemic juvenile idiopathic arthritis monocytes. Clinical Immunology 2012;142:362-72. Go to original source... Go to PubMed...
  8. Devaraj S, Dasu MR, Rockwood J, Winter W, Griffen SC, Jialal I. Increased toll-like receptor (TLR) 2 and TLR4 expression in monocytes from patients with type 1 diabetes: further evidence of a proinflammatory state. J Clin Endocrinol Metab 2008;93:578-83. Go to original source... Go to PubMed...
  9. Devaraj S, Glaser N, Griffen S, Wang-Polagruto J, Miguelino E, Jialal I. Increased monocytic activity and biomarkers of inflammation in patients with type 1 diabetes. Diabetes 2006;55:774-9. Go to original source... Go to PubMed...
  10. Devaraj S, Cheung AT, Jialal I, Griffen SC, Nguyen D, Glaser N, Aoki T. Evidence of increased inflammation and microcirculatory abnormalities in patients with type 1 diabetes and their role in microvascular complications. Diabetes 2007;56:2790-6. Go to original source... Go to PubMed...
  11. Hausmann M, Kiessling S, Mestermann S, Webb G, Spottl T, Andus T, Scholmerich J, Herfarth H, Ray K, Falk W, Rogler G. Toll-like receptors 2 and 4 are up-regulated during intestinal inflammation. Gastroenterology 2002;122:1987-2000. Go to original source... Go to PubMed...
  12. Shao L, Zhang P, Zhang Y, Lu Q, Ma A. TLR3 and TLR4 as potential clinically biomarkers of cardiovascular risk in coronary artery disease (CAD) patients. Heart Vessels 2014;29(5):690-8. Go to original source... Go to PubMed...
  13. Mudaliar H, Pollock C, Komala MG, Chadban S, Wu H, Panchapakesan U. The role of Toll-like receptor proteins (TLR) 2 and 4 in mediating inflammation in proximal tubules. Am J Physiol Renal Physiol 2013;305:F143-F154. Go to original source... Go to PubMed...
  14. Kaizer EC, Glaser CL, Chaussabel D, Banchereau J, Pascual V, White PC. Gene expression in peripheral blood mononuclear cells from children with diabetes. Journal of Clinical Endocrinology & Metabolism 2007;92:3705-11. Go to original source...
  15. Zipris D. Innate immunity and its role in type 1 diabetes. Curr Opin Endocrinol Diabetes Obes 2008;15:326-31. Go to original source... Go to PubMed...
  16. Wang XJ, Jia S, Geoffrey R, Alemzadeh R, Ghosh S, Hessner MJ. Identification of a molecular signature in human type 1 diabetes mellitus using serum and functional genomics. Journal of Immunology 2008;180:1929-37. Go to original source... Go to PubMed...
  17. Dasu MR, Devaraj S, Park S, Jialal I. Increased Toll-Like Receptor (TLR) Activation and TLR Ligands in Recently Diagnosed Type 2 Diabetic Subjects. Diabetes Care 2010;33:861-8. Go to original source... Go to PubMed...
  18. Sherry CL, O'Connor JC, Kramer JM, Freund GG. Augmented lipopolysaccharide-induced TNF-alpha production by peritoneal macrophages in type 2 diabetic mice is dependent on elevated glucose and requires p38 MAPK. Journal of Immunology 2007;178:663-70. Go to original source... Go to PubMed...
  19. Dasu MR, Devaraj S, Zhao L, Hwang DH, Jialal I. High Glucose Induces Toll-Like Receptor Expression in Human Monocytes Mechanism of Activation. Diabetes 2008;57:3090-8. Go to original source... Go to PubMed...
  20. Ben Jonathan N, Mershon JL, Allen DL, Steinmetz RW. Extrapituitary prolactin: distribution, regulation, functions, and clinical aspects. Endocr Rev 1996;17:639-69. Go to PubMed...
  21. Felmet KA, Hall MW, Clark RS, Jaffe R, Carcillo JA. Prolonged lymphopenia, lymphoid depletion, and hypoprolactinemia in children with nosocomial sepsis and multiple organ failure. J Immunol 2005;174:3765-72. Go to original source... Go to PubMed...
  22. Cejkova P, Chroma V, Cerna M, Markova M, Marek J, Lacinova Z, Haluzik M. Monitoring of the Course of Sepsis in Hematooncological Patients by Extrapituitary Prolactin Expression in Peripheral Blood Monocytes. Physiological Research 2012;61:481-8. Go to PubMed...
  23. Leanos-Miranda A, Cardenas-Mondragon G. Serum free prolactin concentrations in patients with systemic lupus erythematosus are associated with lupus activity. Rheumatology (Oxford) 2006;45:97-101. Go to original source... Go to PubMed...
  24. Neidhart M, Gay RE, Gay S. Prolactin and prolactin-like polypeptides in rheumatoid arthritis. Biomed Pharmacother 1999;53:218-22. Go to original source... Go to PubMed...
  25. American Diabetes Association. Diagnosis and classification of diabetes mellitus. Diabetes Care 2008;31:S55-S60. Go to original source... Go to PubMed...
  26. Cerna M, Kolostova K, Novota P, Romzova M, Cejkova P, Pinterova D, Pruhova S, Treslova L, Andel M. Autoimmune diabetes mellitus with adult onset and type 1 diabetes mellitus in children have different genetic predispositions. Ann N Y Acad Sci 2007;1110:140-50. Go to original source... Go to PubMed...
  27. Sabbah E, Savola K, Ebeling T, Kulmala P, Vahasalo P, Ilonen J, Salmela PI, Knip M. Genetic, autoimmune, and clinical characteristics of childhood- and adult-onset type 1 diabetes. Diabetes Care 2000;23:1326-32. Go to original source... Go to PubMed...
  28. Vuckovic S, Withers G, Harris M, Khalil D, Gardiner D, Flesch I, Tepes S, Greer R, Cowley D, Cotterill A, Hart DNJ. Decreased blood dendritic cell counts in type 1 diabetic children. Clinical Immunology 2007;123:281-8. Go to original source... Go to PubMed...
  29. Sousa CRE, Yap G, Schulz O, Rogers N, Schito M, Aliberti J, Hieny S, Sher A. Paralysis of dendritic cell IL-12 production by microbial products prevents infection-induced immunopathology. Immunity 1999;11:637-47. Go to original source... Go to PubMed...
  30. Gregor MF, Hotamisligil GS. Inflammatory Mechanisms in Obesity. Annual Review of Immunology, Vol 29 2011;29:415-45. Go to original source... Go to PubMed...
  31. Renshaw M, Rockwell J, Engleman C, Gewirtz A, Katz J, Sambhara S. Cutting edge: Impaired toll-like receptor expression and function in aging. Journal of Immunology 2002;169:4697-701. Go to original source... Go to PubMed...
  32. Pierre N, Deldicque L, Barbe C, Naslain D, Cani PD, Francaux M. Toll-Like Receptor 4 Knockout Mice Are Protected against Endoplasmic Reticulum Stress Induced by a High-Fat Diet. Plos One 2013;8(5). Go to original source... Go to PubMed...
  33. Mohammad MK, Morran M, Slotterbeck B, Leaman DW, Sun YP, von Grafenstein H, Hong SC, McInerney MF. Dysregulated Toll-like receptor expression and signaling in bone marrow-derived macrophages at the onset of diabetes in the non-obese diabetic mouse. International Immunology 2006;18:1101-13. Go to original source... Go to PubMed...
  34. Ururahy MAG, Loureiro MB, Freire-Neto FP, de Souza KSC, Zuhl I, Brandao-Neto J, Hirata RDC, Doi SD, Arrais RF, Hirata MH, Almeida MD, de Rezende AA. Increased TLR2 expression in patients with type 1 diabetes: evidenced risk of microalbuminuria. Pediatric Diabetes 2012;13:147-54. Go to original source... Go to PubMed...
  35. Stechova K, Spalova I, Durilova M, Bartaskova D, Cerny M, Cerna M, Pithova P, Chudoba D, Stavikova V, Ulmannova T, Faresjo M. Influence of Maternal Hyperglycaemia on Cord Blood Mononuclear Cells in Response to Diabetes-associated Autoantigens. Scandinavian Journal of Immunology 2009;70:149-58. Go to original source... Go to PubMed...
  36. Wurfel MM, Kunitake ST, Lichenstein H, Kane JP, Wright SD. Lipopolysaccharide (Lps)-Binding Protein Is Carried on Lipoproteins and Acts As A Cofactor in the Neutralization of Lps. Journal of Experimental Medicine 1994;180:1025-35. Go to original source... Go to PubMed...
  37. Bas S, James RW, Gabay C. Serum lipoproteins attenuate macrophage activation and Toll-Like Receptor stimulation by bacterial lipoproteins. Bmc Immunology 2010;11(46). Go to original source... Go to PubMed...
  38. Levine DM, Parker TS, Donnelly TM, Walsh A, Rubin AL. In-Vivo Protection Against Endotoxin by Plasma High-Density-Lipoprotein. Proceedings of the National Academy of Sciences of the United States of America 1993;90:12040-4.
  39. Cue JI, Dipiro JT, Brunner LJ, Doran JE, Blankenship ME, Mansberger AR, Hawkins ML, Peck M. Reconstituted High-Density-Lipoprotein Inhibits Physiological and Tumor-Necrosis-Factor-Alpha Responses to Lipopolysaccharide in Rabbits. Archives of Surgery 1994;129:193-7. Go to original source... Go to PubMed...